Life Biosciences
The AI engine Fit Assessment
BetaLife Biosciences develops innovative drug therapies aimed at addressing age-related diseases and promoting healthier aging. Their research focuses on targeting biological mechanisms that contribute to the aging process.
Blurb
Life Biosciences is a developer of drugs designed to promote longevity and find treatments for age-related diseases.
HQ Location
United States
Founded
2017
Employees
11 - 50
Total funding raised
$206.77M
Last Funding Event
Series C, $82.00M, January 5, 2022
Smart insights
- Mehmood Khan (Chief Executive Officer) has 5 years of experience in the Life Sciences industry at Takeda
- Mehmood Khan (Chief Executive Officer) has 13 years of experience in the Biotechnology industry at companies such as Takeda, Mayo Clinic and HemoShear Therapeutics
- 6m headcount growth: -4%
- 1Y headcount growth: 4%
- Headcount-to-last-round ratio: 0.5 employees/$M
Developer of drug therapies intended to improve the lives of people as they age. The company's drugs help to combat the eight pathways of age-related decline and its work addresses health decline due to aging as a systemic breakdown of the body, rather than a series of isolated events and conditions, enabling senior citizens to tackle age-related diseases to extend healthy life spans.